A patient with rheumatoid arthritis who had a normal delivery under etanercept treatment

Internal Medicine

Volumn 49, Issue 2, 2010, Pages 187-189

  Umeda, Naoto ^a   Ito, Satoshi ^a   Hayashi, Taichi ^a   Goto, Daisuke ^a   Matsumoto, Isao ^a   Sumida, Takayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Biologics; Etanercept; Pregnancy; Rheumatoid arthritis

Indexed keywords

BUCILLAMINE; C REACTIVE PROTEIN; ETANERCEPT; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DISEASE ACTIVITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; JOINT SWELLING; PAIN ASSESSMENT; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; DELIVERY, OBSTETRIC; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 75749106673     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.2439     Document Type: Article

References (10)

1. Roux CH, Brocq O, Breuil V, Albert C, Euller-Ziegler L. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy. Rheumatology (Oxford) 46: 695-698, 2007.
2. Berthelot JM, De Bandt M, Goupille P, et al. Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature. Joint Bone Spine 76: 28-34, 2009.
3. Murashima A. Treatment of patients with rheumatoid arthritis who desire to become pregnant-successful pregnancy in three cases treated with etanercept. Nippon Rinsho 66: 2215-2220, 2008 (In Japanese, Abstract in English).
4. Briggs GG, Roger KK, Sumner JY. Drugs in Pregnancy and Lactation. 7th ed. Williams and Wilkins, Baltimore, 2005.
5. Sinha A, Patient C. Rheumatoid arthritis in pregnancy: successful outcome with anti-TNF agent (Etanercept). J Obstet Gynaecol 26: 689-691, 2006.
6. Fransen J, van Riel PL. The disease activity score and the EULAR response criteria. Clin Exp Rheumatol 23: S93-S99, 2005.
7. Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod Toxicol 25: 271-275, 2008.
8. Cush JJ. Biological drug use: US perspective on indications and monitoring. Ann Rheum Dis 64: iv18-iv23, 2005.
9. Koike R, Takeuchi T, Eguchi K, Miyasaka N. Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis. Mod Rheumatol 17: 451-458, 2007.
10. Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut 54: 890, 2005.